Coprophilous fungus capsule based on coprophilous fungus thalli and preparation method thereof
By using specific raw materials and preparation methods in fecal bacteria capsules, the problems of low activity and poor colonization effect during storage and use of fecal bacteria transplant capsules are solved, and high bacterial loading rate and long survival time are achieved and good colonization effect.
Patent Information
- Application Number
- CN202411184069.4
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2024-08-27
- Publication Date
- 2024-11-08
- Estimated Expiration
- Not applicable · inactive patent
AI Technical Summary
The existing fecal bacteria transplant capsules have problems such as low activity, low survival rate and poor colonization effect during storage and use, especially poor tolerance to gastric acid and digestive enzymes, resulting in poor transplantation effect.
A fecal bacteria capsule based on fecal bacteria, whose raw materials include fresh feces, glutamic acid, skim milk, mannitol, fructose, vitamin C, lanthanum carbonate, sodium alginate and dopamine, to form the intestine through specific preparation methods Soluce capsules use the cross-linked structure of polydopamine and sodium alginate to enhance the survival and adhesion of fecal bacteria and prolong the release time in the intestine.
It significantly improves the storage stability and activity of fecal bacteria capsules, extends survival time, enhances colonization ability and transplantation effect in the intestines, ensures high bacterial loading rate and high activity, and has good biocompatibility and resistance. Pressure.
Smart Images

Figure CN118903059A_ABST
Abstract
Description
Technical Field
[0001] The present invention relates to the technical field of oral microbial preparations, and in particular to a fecal bacteria capsule based on fecal bacteria bodies and a preparation method thereof. Background Art
[0002] The intestinal microbial ecosystem is the most complex and largest micro-ecosystem in mammals. However, the current large-scale use of antibiotics and changes in dietary structure have greatly changed the composition of human intestinal microorganisms, destroying the normal intestinal flora and causing the emergence of some new diseases.
[0003] "Fecal microbiota transplantation" is to transplant the functional flora in the feces of healthy people into the intestines of patients, reshape the intestinal flora with normal functions, restore the intestinal microecology of patients, and achieve the treatment of intestinal and extraintestinal diseases. Fecal microbiota transplantation has been regarded as a special organ transplantation, used to treat Clostridium difficile infection, inflammatory bowel disease, irritable bowel syndrome, metabolic syndrome, neurodevelopmental dysplasia and neurodegenerative diseases, autoimmune enteropathy, intestinal food allergies and many other diseases.
[0004] Fecal microbiota transplantation can be administered through three routes: upper gastrointestinal tract, middle gastrointestinal tract, and lower gastrointestinal tract. The upper gastrointestinal tract route mainly refers to oral fecal microbiota capsules, which are non-invasive and highly accepted by patients, and are most easily accepted by patients, so they have the broadest application prospects.
[0005] There are various methods for preparing fecal microbiota transplantation liquid. After freeze-drying, the microbiota capsules have obvious odor and the bacterial quantity and activity are low, resulting in unsatisfactory transplantation effects. In addition, since most intestinal microbiota have poor tolerance to gastric acid, bile salts and various digestive enzymes in the digestive tract, the survival rate of the microbiota is low when passing through the gastrointestinal tract.
[0006] Although the enteric-coated capsule shell can prevent it from being dissolved by gastric juice, its storage effect is poor and the bacterial flora is easily inactivated. At the same time, only a small part of the fecal bacterial fluid remains attached to the intestinal wall after dissolution, and the effect of fecal microbiota transplantation is not ideal.
[0007] At present, the storage time of fecal bacteria at room temperature is short. For long-term storage, sterile glycerol must be added and then frozen at -80℃, which is inconvenient to use. How to provide a bacterial capsule with high bacterial load rate, high activity, high colonization rate, and improve storage stability has excellent application prospects. Summary of the invention
[0008] The purpose of the present invention is to solve the shortcomings of the prior art and to propose a fecal bacteria capsule based on fecal bacteria and a preparation method thereof.
[0009] A fecal bacteria capsule based on fecal bacteria, wherein the raw materials include, by mass, 100-150 parts of fresh fecal samples from a donor, 1.5-3 parts of glutamic acid, 5-10 parts of skim milk, 3-5 parts of mannitol, 5-15 parts of fructose, 0.1-1 part of vitamin C, 0.001-0.1 part of lanthanum carbonate, 1-5 parts of sodium alginate, 200-500 parts of a calcium chloride solution with a concentration of 0.1-0.5 mol / L, 50-100 parts of a dopamine aqueous solution with a concentration of 1-2 g / L, and 0.025-0.12 parts of gum arabic.
[0010] Among them, donors are selected from high-quality college students, and recipients are transplanted after precise matching through metagenomic sequencing.
[0011] Preferably, the number of live bacteria in the fecal bacteria capsule is ≥ 2.5×10 11 cfu / grain.
[0012] The method for preparing the fecal bacteria capsule based on fecal bacteria cells comprises the following steps: S1. Add the fresh fecal sample of the donor into physiological saline, mix evenly, filter, homogenize, filter step by step, centrifuge for 5-20 minutes, and obtain the precipitate; S2, adding glutamic acid, skim milk, mannitol, fructose, vitamin C, lanthanum carbonate, and sodium alginate to normal saline and stirring evenly, adding the precipitate thereto and stirring evenly to obtain a suspension; S3, adding the suspension dropwise to the calcium chloride solution and stirring for 10-20 minutes, washing with sterile saline, vacuum drying, adding to the dopamine aqueous solution, adjusting the pH value of the system to 7.1-7.5, ultrasonic treatment for 1-2 hours, washing with sterile saline, cooling from 25-30°C to -70--80°C, pre-freezing for 12-24 hours, and vacuum drying to obtain a blank; S4. Under stirring condition, spray the gum arabic aqueous solution on the surface of the blank and stir evenly, dry under vacuum, pack into enteric-coated capsules, and store anaerobically at low temperature.
[0013] Preferably, in S1, the specific operation of the step-by-step filtration is: the homogenized slurry is filtered step by step using molecular sieves with diameters of 2.0 mm, 1.0 mm, 0.4 mm and 0.1 mm in sequence.
[0014] Preferably, in S1, the centrifugal speed is 2000-4000 r / min.
[0015] Preferably, in S3, a Tris-HCl solution with a pH value of 8-9 is used to adjust the pH value of the system to 7.1-7.5.
[0016] Preferably, in S3, during the process of cooling from 25-30°C to -70-80°C, the temperature is firstly cooled to -5-10°C at a rate of 1-2°C / min, and then cooled to -70-80°C at a rate of 3-5°C / min.
[0017] Preferably, in S3, the vacuum drying temperature is -40 to -60°C, the vacuum drying time is 24 to 48 hours, and the vacuum degree is 8 to 12 Pa.
[0018] Preferably, in S3, the temperature of anaerobic low-temperature storage is -40 to -60°C.
[0019] The above-mentioned method of using the fecal microbiota capsule based on fecal microbiota is to transplant the number of live bacteria in a single fecal microbiota transplantation ≥ 2.5×10 12 cfu . Beneficial Effects
[0020] When the outermost layer of enteric-coated capsules of the present invention ruptures, the hydrogel network of the gelatin layer can effectively delay the molecular diffusion of fecal bacteria in the microgel structure, and can reduce the release rate of fecal bacteria in the intestine; however, gelatin is highly hydrophilic, and once dissolved, fecal bacteria can be easily discharged from the intestine prematurely. The present invention uses a compound of polydopamine and gelatin attached to the surface of the microcapsule, which can greatly prolong the release time of fecal bacteria in the intestine, and can effectively increase the adhesion strength of fecal bacteria to the intestinal wall, greatly improving the effect of fecal bacteria transplantation.
[0021] Since the inner layer of sodium alginate has obvious pH sensitivity, and the gel pores formed by cross-linking with calcium ions are large, it is easy to have the defect of gastric acid penetration. By coating the outer layer with polydopamine, polydopamine can not only effectively fill the pores, but also has high binding strength to effectively prevent gastric acid penetration, and its high bonding strength can effectively adsorb to the intestinal wall surface after the outer layer of gelatin structure dissolves, which can promote the colonization of fecal bacteria in the gastrointestinal tract.
[0022] Lanthanum carbonate can not only significantly enhance the storage activity of fecal bacteria, but also cooperate with sodium alginate solidification coating, polydopamine and gelatin coating in sequence to greatly enhance the storage stability of fecal bacteria. Experiments have confirmed that the fecal bacteria capsules obtained by the present invention have excellent stability under the conditions of -80°C, -20°C and 4°C, and their storage time is up to 12 months. The storage conditions of fecal bacteria are wider and can maintain extremely high activity. At the same time, lanthanum carbonate cooperates with polydopamine in the intestines, which has a significant stimulating effect on the early colonization and growth of fecal bacteria, quickly improves the activity of the flora, and has a significant oral effect.
[0023] The present invention greatly improves the adaptability and survival ability of fecal bacteria to the environment. It not only has good stability, high biocompatibility, low toxicity, good pressure resistance, and can effectively prevent fecal bacteria from overflowing during transportation, but also has a simple preparation method and low cost. BRIEF DESCRIPTION OF THE DRAWINGS
[0024] Figure 1 The fecal bacteria activity retention curve of the fecal bacteria capsules obtained in Example 5 and Comparative Examples 1-2 stored at different temperatures (-80°C, -20°C and 4°C) for 12 months.
[0025] Figure 2 The figure is a comparison chart of the breakage rates of the fecal fungus capsules obtained in Example 5 and Comparative Examples 1-2.
[0026] Figure 3 This is the cumulative release rate curve of the fecal bacteria capsules obtained in Example 5 and Comparative Examples 1-2 in artificial intestinal fluid.
[0027] Figure 4 It is a comparison chart of ACE index and Chao1 index of Example 5 group, Comparative Example 1-2 group and control group. DETAILED DESCRIPTION
[0028] The present invention will be further explained below in conjunction with specific embodiments.
[0029] The enteric-coated capsules used below were purchased from Ningbo Fengyuan Capsule Co., Ltd. Example
[0030] A fecal bacteria capsule based on fecal bacteria, whose raw materials include: 100g of fresh fecal sample from a donor, 1.5g of glutamic acid, 5g of skim milk, 3g of mannitol, 5g of fructose, 0.1g of vitamin C, 0.001g of food-grade lanthanum carbonate, 1g of sodium alginate, 200g of calcium chloride solution with a concentration of 0.1mol / L, 50g of dopamine aqueous solution with a concentration of 1g / L, and 0.025g of gum arabic.
[0031] The method for preparing the fecal bacteria capsule based on fecal bacteria cells comprises the following steps: S1. Place the donor's fresh fecal sample into a blender, add 200g of physiological saline to mix evenly, filter to remove large particles, place into a beating homogenizer for homogenization for 180s (homogenizer power is 165W, beating speed is 3 times / s), filter through molecular sieves with diameters of 2.0mm, 1.0mm, 0.4mm, and 0.1mm step by step, and then centrifuge at a speed of 2000r / min for 5min to obtain a precipitate; S2, adding glutamic acid, skim milk, mannitol, fructose, vitamin C, lanthanum carbonate, and sodium alginate to 100 g of normal saline and stirring evenly, adding the precipitate thereto and stirring evenly at a stirring speed of 2000 r / min to obtain a suspension; S3, adding the suspension dropwise to the calcium chloride solution, stirring at a speed of 500r / min for 10min, rinsing with sterile saline, vacuum drying, adding to the dopamine aqueous solution, adjusting the pH value of the system to 7.1-7.5 with a Tris-HCl solution with a pH value of 8-9, ultrasonically treating for 1h, rinsing with sterile saline; cooling from 25°C to -5°C at a speed of 1°C / min, and then cooling to -70°C at a speed of 3°C / min, pre-freezing for 12h; vacuum drying at -40°C for 24h, with a vacuum degree of 8Pa, to obtain a blank; S4. While stirring, spray 0.5% gum arabic aqueous solution on the surface of the blank and stir evenly, dry under vacuum, and pack into enteric-coated capsules at a specification of 0.1 g / capsule, and store at -40°C anaerobic low temperature.
[0032] After inspection, the number of live bacteria in the fecal bacteria capsule obtained in this example was 2.6×10 11 cfu / grain. Example
[0033] A fecal bacteria capsule based on fecal bacteria, whose raw materials include: 150g of fresh fecal sample from a donor, 3g of glutamic acid, 10g of skim milk, 5g of mannitol, 15g of fructose, 1g of vitamin C, 0.1g of food-grade lanthanum carbonate, 5g of sodium alginate, 500g of 0.5mol / L calcium chloride solution, 100g of 2g / L dopamine aqueous solution, and 0.12g of gum arabic.
[0034] The method for preparing the fecal bacteria capsule based on fecal bacteria cells comprises the following steps: S1. Place the donor's fresh fecal sample into a blender, add 300g of physiological saline to mix evenly, filter to remove large particles, place into a beating homogenizer for homogenization for 180s (homogenizer power is 165W, beating speed is 12 times / s), filter through molecular sieves with diameters of 2.0mm, 1.0mm, 0.4mm, and 0.1mm step by step, and then centrifuge at a speed of 4000r / min for 20min to obtain a precipitate; S2, adding glutamic acid, skim milk, mannitol, fructose, vitamin C, lanthanum carbonate, and sodium alginate to 100 g of normal saline and stirring evenly, adding the precipitate thereto and stirring evenly at a stirring speed of 4000 r / min to obtain a suspension; S3, adding the suspension dropwise to the calcium chloride solution, stirring at a speed of 1500r / min for 20min, rinsing with sterile saline, vacuum drying, adding to the dopamine aqueous solution, adjusting the pH value of the system to 7.1-7.5 with a Tris-HCl solution with a pH value of 8-9, ultrasonically treating for 2h, rinsing with sterile saline; cooling from 30°C to -10°C at a speed of 2°C / min, and then cooling to -80°C at a speed of 5°C / min, pre-freezing for 24h; vacuum drying at -60°C for 48h, with a vacuum degree of 12Pa, to obtain a blank; S4. While stirring, spray 1.2% gum arabic aqueous solution on the surface of the blank and stir evenly, dry under vacuum, and pack into enteric-coated capsules at a specification of 0.1 g / capsule, and store at -60°C anaerobic low temperature.
[0035] After inspection, the number of viable bacteria in the fecal bacteria capsule obtained in this example was 6.1×10 11 cfu / grain. Example
[0036] A fecal bacteria capsule based on fecal bacteria, whose raw materials include: 110g of fresh fecal sample from a donor, 2.8g of glutamic acid, 7g of skim milk, 4.5g of mannitol, 8g of fructose, 0.7g of vitamin C, 0.01g of food-grade lanthanum carbonate, 4g of sodium alginate, 400g of calcium chloride solution with a concentration of 0.2mol / L, 90g of dopamine aqueous solution with a concentration of 1.2g / L, and 0.06g of gum arabic.
[0037] The method for preparing the fecal bacteria capsule based on fecal bacteria cells comprises the following steps: S1. Place the donor's fresh fecal sample into a blender, add 280 g of physiological saline to mix evenly, filter to remove large particles, place into a beating homogenizer for homogenization for 180 seconds (homogenizer power is 165 W, beating speed is 6 times / s), filter through molecular sieves with diameters of 2.0 mm, 1.0 mm, 0.4 mm, and 0.1 mm step by step, and then centrifuge at a speed of 3400 r / min for 8 minutes to obtain a precipitate; S2, adding glutamic acid, skim milk, mannitol, fructose, vitamin C, lanthanum carbonate, and sodium alginate to 100 g of normal saline and stirring evenly, adding the precipitate thereto and stirring evenly at a stirring speed of 3500 r / min to obtain a suspension; S3, adding the suspension dropwise to the calcium chloride solution, stirring at a speed of 800r / min for 18min, rinsing with sterile saline, vacuum drying, adding to the dopamine aqueous solution, adjusting the pH value of the system to 7.1-7.5 with a Tris-HCl solution with a pH value of 8-9, ultrasonic treatment for 80min, rinsing with sterile saline; cooling from 29°C to -9°C at a speed of 1.2°C / min, and then cooling to -77°C at a speed of 3.5°C / min, pre-freezing for 15h; vacuum drying at -55°C for 30h, with a vacuum degree of 11Pa, to obtain a blank; S4. While stirring, spray 0.6% gum arabic aqueous solution on the surface of the blank and stir evenly, dry under vacuum, and pack into enteric-coated capsules at a specification of 0.1 g / capsule, and store at -55°C anaerobic low temperature.
[0038] After inspection, the number of live bacteria in the fecal bacteria capsule obtained in this example was 8.1×10 11 cfu / grain. Example
[0039] A fecal bacteria capsule based on fecal bacteria, whose raw materials include: 130g of fresh fecal sample from a donor, 2g of glutamic acid, 9g of skim milk, 3.5g of mannitol, 12g of fructose, 0.3g of vitamin C, 0.07g of food-grade lanthanum carbonate, 2g of sodium alginate, 300g of calcium chloride solution with a concentration of 0.4mol / L, 70g of dopamine aqueous solution with a concentration of 1.8g / L, and 0.1g of gum arabic.
[0040] The method for preparing the fecal bacteria capsule based on fecal bacteria cells comprises the following steps: S1. Place the donor's fresh fecal sample into a blender, add 220 g of physiological saline to mix evenly, filter to remove large particles, place into a beating homogenizer for homogenization for 180 seconds (homogenizer power is 165 W, beating speed is 9 times / s), filter through molecular sieves with diameters of 2.0 mm, 1.0 mm, 0.4 mm, and 0.1 mm step by step, and then centrifuge at a speed of 2800 r / min for 16 minutes to obtain a precipitate; S2, adding glutamic acid, skim milk, mannitol, fructose, vitamin C, lanthanum carbonate, and sodium alginate to 100 g of normal saline and stirring evenly, adding the precipitate thereto and stirring evenly at a stirring speed of 2500 r / min to obtain a suspension; S3, adding the suspension dropwise to the calcium chloride solution, stirring at a speed of 1200r / min for 12min, rinsing with sterile saline, vacuum drying, adding to the dopamine aqueous solution, adjusting the pH value of the system to 7.1-7.5 with a Tris-HCl solution with a pH value of 8-9, ultrasonic treatment for 100min, rinsing with sterile saline; cooling from 27°C to -7°C at a speed of 1.8°C / min, and then cooling to -73°C at a speed of 4.5°C / min, pre-freezing for 21h; vacuum drying at -45°C for 42h, with a vacuum degree of 9Pa, to obtain a blank; S4. While stirring, spray 1% gum arabic aqueous solution on the surface of the blank and stir evenly, dry under vacuum, and pack into enteric-coated capsules at a specification of 0.1 g / capsule, and store at -45°C anaerobic low temperature.
[0041] After inspection, the number of live bacteria in the fecal bacteria capsule obtained in this example was 7.4×10 11 cfu / grain. Example
[0042] A fecal bacteria capsule based on fecal bacteria, whose raw materials include: 120g of fresh fecal sample from a donor, 2.5g of glutamic acid, 8g of skim milk, 4g of mannitol, 10g of fructose, 0.5g of vitamin C, 0.04g of food-grade lanthanum carbonate, 3g of sodium alginate, 350g of 0.3mol / L calcium chloride solution, 80g of 1.5g / L dopamine aqueous solution, and 0.08g of gum arabic.
[0043] The method for preparing the fecal bacteria capsule based on fecal bacteria cells comprises the following steps: S1. Place the donor's fresh fecal sample into a blender, add 250g of physiological saline to mix evenly, filter to remove large particles, place into a beating homogenizer for homogenization for 180s (homogenizer power is 165W, beating speed is 8 times / s), filter through molecular sieves with diameters of 2.0mm, 1.0mm, 0.4mm, and 0.1mm step by step, and then centrifuge at a speed of 3200r / min for 12min to obtain a precipitate; S2, adding glutamic acid, skim milk, mannitol, fructose, vitamin C, lanthanum carbonate, and sodium alginate to 100 g of normal saline and stirring evenly, adding the precipitate thereto and stirring evenly at a stirring speed of 3000 r / min to obtain a suspension; S3, adding the suspension dropwise to the calcium chloride solution, stirring at a speed of 1000r / min for 15min, rinsing with sterile saline, vacuum drying, adding to the dopamine aqueous solution, adjusting the pH value of the system to 7.1-7.5 with a Tris-HCl solution with a pH value of 8-9, ultrasonic treatment for 90min, rinsing with sterile saline; cooling from 28°C to -8°C at a speed of 1.5°C / min, and then cooling to -75°C at a speed of 4°C / min, pre-freezing for 18h; vacuum drying at -50°C for 36h, with a vacuum degree of 10Pa, to obtain a blank; S4. While stirring, spray 0.8% gum arabic aqueous solution on the surface of the blank and stir evenly, dry under vacuum, and pack into enteric-coated capsules at a specification of 0.1 g / capsule, and store at -50°C anaerobic low temperature.
[0044] After inspection, the number of live bacteria in the fecal bacteria capsule obtained in this example was 9.3×10 11 cfu / grain.
[0045] Comparative Example 1 A fecal bacteria capsule based on fecal bacteria, whose raw materials include: 120g of fresh fecal sample from a donor, 2.5g of glutamic acid, 8g of skim milk, 4g of mannitol, 10g of fructose, 0.5g of vitamin C, 0.04g of food-grade calcium carbonate, 3g of sodium alginate, 350g of 0.3mol / L calcium chloride solution, 80g of 1.5g / L dopamine aqueous solution, and 0.08g of gum arabic.
[0046] The method for preparing the fecal bacteria capsule based on fecal bacteria cells comprises the following steps: S1. Place the donor's fresh fecal sample into a blender, add 250g of physiological saline to mix evenly, filter to remove large particles, place into a beating homogenizer for homogenization for 180s (homogenizer power is 165W, beating speed is 8 times / s), filter through molecular sieves with diameters of 2.0mm, 1.0mm, 0.4mm, and 0.1mm step by step, and then centrifuge at a speed of 3200r / min for 12min to obtain a precipitate; S2, adding glutamic acid, skim milk, mannitol, fructose, vitamin C, calcium carbonate, and sodium alginate to 100 g of normal saline and stirring evenly, adding the precipitate thereto and stirring evenly at a stirring speed of 3000 r / min to obtain a suspension; S3, adding the suspension dropwise to the calcium chloride solution, stirring at a speed of 1000r / min for 15min, rinsing with sterile saline, vacuum drying, adding to the dopamine aqueous solution, adjusting the pH value of the system to 7.1-7.5 with a Tris-HCl solution with a pH value of 8-9, ultrasonic treatment for 90min, rinsing with sterile saline; cooling from 28°C to -8°C at a speed of 1.5°C / min, and then cooling to -75°C at a speed of 4°C / min, pre-freezing for 18h; vacuum drying at -50°C for 36h, with a vacuum degree of 10Pa, to obtain a blank; S4. While stirring, spray 0.8% gum arabic aqueous solution on the surface of the blank and stir evenly, dry under vacuum, and pack into enteric-coated capsules at a specification of 0.1 g / capsule, and store at -50°C anaerobic low temperature.
[0047] Comparative Example 2 A fecal bacteria capsule based on fecal bacteria, whose raw materials include: 120g of fresh fecal sample from a donor, 2.5g of glutamic acid, 8g of skim milk, 4g of mannitol, 10g of fructose, 0.5g of vitamin C, 0.04g of food-grade lanthanum carbonate, 3g of sodium alginate, 350g of 0.3mol / L calcium chloride solution, 80g of 1.5g / L dopamine aqueous solution, and 0.08g of gum arabic.
[0048] The method for preparing the fecal bacteria capsule based on fecal bacteria cells comprises the following steps: S1. Place the donor's fresh fecal sample into a blender, add 250g of physiological saline to mix evenly, filter to remove large particles, place into a beating homogenizer for homogenization for 180s (homogenizer power is 165W, beating speed is 8 times / s), filter through molecular sieves with diameters of 2.0mm, 1.0mm, 0.4mm, and 0.1mm step by step, and then centrifuge at a speed of 3200r / min for 12min to obtain a precipitate; S2, adding glutamic acid, skim milk, mannitol, fructose, vitamin C, lanthanum carbonate, and sodium alginate to 100 g of normal saline and stirring evenly, adding the precipitate thereto and stirring evenly at a stirring speed of 3000 r / min to obtain a suspension; S3, adding the suspension dropwise to the calcium chloride solution, stirring at a speed of 1000r / min for 15min, and washing with sterile physiological saline; cooling from 28°C to -8°C at a speed of 1.5°C / min, and then cooling to -75°C at a speed of 4°C / min, pre-freezing for 18h; vacuum drying at -50°C for 36h, with a vacuum degree of 10Pa, to obtain a blank; S4. Under stirring, spray an aqueous solution of arabic gum with a mass fraction of 0.8% onto the surface of the blank, stir evenly, dry under vacuum, and fill it into enteric capsules according to the specification of 0.1 g / granule, and store it at -50 °C under anaerobic and low temperature conditions.
[0049] The fecal microbiota capsules obtained in Example 5 and Comparative Examples 1-2 were used for comparative testing. Among them, all the fresh fecal samples used in this experiment were from 3 healthy在校大学生 (aged 18-21) with a healthy lifestyle, no smoking or alcohol habits; normal defecation, no previous chronic diseases such as constipation and irritable bowel syndrome (IBD), no autoimmune diseases or immunosuppressive states, and no history of malignancy; no gastrointestinal-related diseases; no metabolic syndrome (18.5 < BMI < 25), autoimmune diseases, or allergic diseases; no history of oral or intravenous antibiotic use in the past 6 months; no history of traveling to infectious disease epidemic areas in the past 6 months).
[0050] The fecal microbiota capsules obtained in Example 5 and Comparative Examples 1-2 were stored at -80 °C, -20 °C, and 4 °C for 12 months respectively, and samples were taken at 0 month, 1 month, 3 months, and 12 months, and diluted to 10 -5 , and anaerobic culture was carried out using Columbia blood agar medium (cultured at 36 °C for 48 h), and the colonies on the plate were observed and counted.
[0051] Fecal microbiota activity retention rate = colony forming unit of a certain group after storage at a certain temperature for a corresponding time ÷ original colony forming unit of the group × 100% As Figure 1 shown, the fecal microbiota capsules obtained in Example 5 still maintained extremely high activity after being stored at various temperatures for 12 months, while the fecal microbiota capsules obtained in Comparative Examples 1-2 showed a relatively rapid decline in fecal microbiota activity after being stored at 4 °C for 12 months. It is confirmed that the fecal microbiota capsules obtained by the present invention have excellent stability, a storage time of up to 12 months, and a wider range of storage conditions, and can still maintain extremely high activity.
[0052] Apply pressure to the fecal microbiota capsules obtained in Example 5 and Comparative Examples 1-2 (pressure aperture area 5 cm 2 , 50 kg, pressure time 3 min), after rinsing with sterile normal saline, peeling off the enteric capsules, centrifuging the remaining materials, and then carrying out anaerobic culture using Columbia blood agar medium (cultured at 36 °C for 48 h), observing the colonies on the plate and counting.
[0053] Fragmentation rate = 1 - colony forming unit of a certain group after pressure application and culture ÷ original colony forming unit of the group × 100% As Figure 2 shown, the fecal microbiota capsules obtained in Example 5 had the lowest fragmentation rate and the best anti-pressure and anti-fragmentation performance, which was better than those of Comparative Examples 1-2 (P < 0.05).
[0054] 1 g of the fecal bacteria capsules obtained in Example 5 and Comparative Examples 1-2 were placed in 20 mL of artificial intestinal fluid, respectively, and shaken at 37°C and 180 rpm for 240 min. Artificial intestinal fluid was taken and supplemented with fresh artificial intestinal fluid every 30 min. The artificial intestinal fluid was centrifuged, the number of viable bacteria was detected, and the cumulative release rate was calculated.
[0055] like Figure 3 As shown, the cumulative release curves of the fecal fungus capsules obtained in Example 5 and Comparative Example 1 are similar, but better than the cumulative release curve of the fecal fungus capsules obtained in Comparative Example 2 (the enteric-coated sustained-release effect of Example 5 and Comparative Example 1 is better, P < 0.05). The cumulative release curve of the fecal fungus capsules obtained in Example 5 is slightly lower than that of Comparative Example 1, which proves that the fecal fungus capsules obtained in the present invention have good enteric solubility and sustained-release properties.
[0056] C57BL / 6J male mice were used as experimental subjects. 10-week-old C57BL / 6J male mice (weight 18-22 g) were randomly divided into 4 groups, namely Example 5 group, Comparative Example 1 group, Comparative Example 2 group and control group. The breeding environment was as follows: room temperature 25±2°C, relative humidity 50-70%, 12h day and night cycle, free access to water and food.
[0057] A mixed antibiotic solution was prepared by dissolving 100 mg / kg of ampicillin, neomycin, and bacitracin, 50 mg / kg of vancomycin and imipenem, and 1 mg / kg of amphotericin B in sterile PBS solution.
[0058] Each group of mice was gavaged with mixed antibiotics (200 μL / d) for 2 weeks, and then the Example 5 group, the Comparative Example 1 group, and the Comparative Example 2 group were gavaged with fecal bacteria capsules obtained in Example 5, Comparative Example 1, and Comparative Example 2, once a day, 1 capsule each time, for 2 weeks; while the control group was not intervened. After the experiment, the feces of the mice were collected and frozen in a -80°C refrigerator for later use.
[0059] Fecal DNA was extracted according to the kit and then PCR amplified. The PCR reaction program was: 98℃ pre-denaturation for 1min, 98℃ denaturation for 10s, 50℃ annealing for 30s, 72℃ extension for 30s, a total of 30 cycles, and 72℃ final extension for 5min. The Alpha diversity of the intestinal flora of the samples was analyzed.
[0060] like Figure 4 As shown, the ACE index and Chao1 index of the Example 5 group are both the highest, indicating that its community species are the richest, confirming that the fecal bacteria capsule obtained in Example 5 can promote the colonization of fecal bacteria in the intestine and promote the early colonization and growth of fecal bacteria.
[0061] The applicant believes that the reason for the above results is that when the outermost enteric-coated capsule of the present invention is broken, the hydrogel network of the gelatin layer can effectively delay the molecular diffusion of fecal bacteria in the microgel structure, and can reduce the release rate of fecal bacteria in the intestine; the present invention uses polydopamine and gelatin attached to the surface of the microcapsule to greatly extend the release time of fecal bacteria in the intestine, and can effectively increase the adhesion strength of fecal bacteria on the intestinal wall, greatly improving the effect of fecal bacteria transplantation. Because the inner layer of sodium alginate has obvious pH sensitivity, and the gel pores formed by cross-linking with calcium ions are large, it is easy to have the defect of gastric acid infiltration. By coating the outer layer with polydopamine, polydopamine can not only effectively fill the pores, but also has high bonding strength, effectively preventing gastric acid from infiltrating, and its bonding strength is high. After the outer layer of gelatin structure is dissolved, it can be effectively adsorbed to the surface of the intestinal wall, which can promote the colonization of fecal bacteria in the intestine. Lanthanum carbonate can not only significantly enhance the storage activity of fecal bacteria, but also cooperate with sodium alginate solidification coating, polydopamine and gelatin coating in sequence to greatly enhance the storage stability of fecal bacteria. At the same time, lanthanum carbonate cooperates with polydopamine in the intestines, which has a significant stimulating effect on the early colonization and growth of fecal bacteria, rapidly increases the activity of the flora, and has a significant oral effect.
[0062] The above description is only a preferred specific implementation manner of the present invention, but the protection scope of the present invention is not limited thereto. Any technician familiar with the technical field can make equivalent replacements or changes according to the technical scheme and inventive concept of the present invention within the technical scope disclosed by the present invention, which should be covered by the protection scope of the present invention.
Claims
1. A fecal bacteria capsule based on fecal bacteria, characterized in that: The raw materials include, by mass, 100-150 parts of fresh fecal samples from donors, 1.5-3 parts of glutamic acid, 5-10 parts of skim milk, 3-5 parts of mannitol, 5-15 parts of fructose, 0.1-1 parts of vitamin C, 0.001-0.1 parts of lanthanum carbonate, 1-5 parts of sodium alginate, 200-500 parts of calcium chloride solution with a concentration of 0.1-0.5 mol / L, 50-100 parts of dopamine aqueous solution with a concentration of 1-2 g / L, and 0.025-0.12 parts of gum arabic.
2. The fecal bacteria capsule based on fecal bacteria according to claim 1, characterized in that: The number of live bacteria in the fecal bacteria capsule is ≥2.5×10 11 cfu / grain.
3. A method for preparing a fecal fungus capsule based on fecal fungus cells as claimed in claim 1 or 2, characterized in that: The steps include: S1. Add the fresh fecal sample of the donor into physiological saline, mix evenly, filter, homogenize, filter step by step, centrifuge for 5-20 minutes, and obtain the precipitate; S2, adding glutamic acid, skim milk, mannitol, fructose, vitamin C, lanthanum carbonate, and sodium alginate to normal saline and stirring evenly, adding the precipitate thereto and stirring evenly to obtain a suspension; S3, adding the suspension dropwise to the calcium chloride solution and stirring for 10-20 minutes, washing with sterile saline, vacuum drying, adding to the dopamine aqueous solution, adjusting the pH value of the system to 7.1-7.5, ultrasonic treatment for 1-2 hours, washing with sterile saline, cooling from 25-30°C to -70--80°C, pre-freezing for 12-24 hours, and vacuum drying to obtain a blank; S4. Under stirring condition, spray the gum arabic aqueous solution on the surface of the blank and stir evenly, dry under vacuum, pack into enteric-coated capsules, and store anaerobically at low temperature.
4. The method for preparing fecal fungus capsules based on fecal fungus cells according to claim 3, characterized in that: In S1, the specific operation of the step-by-step filtration is: the slurry after homogenization is filtered step by step using molecular sieves with diameters of 2.0 mm, 1.0 mm, 0.4 mm, and 0.1 mm in sequence.
5. The method for preparing fecal fungus capsules based on fecal fungus cells according to claim 3, characterized in that: In S1, the centrifugal speed is 2000-4000 r / min.
6. The method for preparing fecal fungus capsules based on fecal fungus cells according to claim 3, characterized in that: In S3, a Tris-HCl solution with a pH value of 8-9 is used to adjust the pH value of the system to 7.1-7.
5.
7. The method for preparing fecal fungus capsules based on fecal fungus cells according to claim 3, characterized in that: In S3, during the process of cooling from 25-30°C to -70-80°C, the temperature is firstly cooled to -5-10°C at a rate of 1-2°C / min, and then cooled to -70-80°C at a rate of 3-5°C / min.
8. The method for preparing fecal fungus capsules based on fecal fungus cells according to claim 3, characterized in that: In S3, the vacuum drying temperature is -40 to -60°C, the vacuum drying time is 24 to 48 hours, and the vacuum degree is 8 to 12 Pa.
9. The method for preparing fecal fungus capsules based on fecal fungus cells according to claim 3, characterized in that: In S3, the temperature of anaerobic low-temperature storage is -40 to -60°C.
10. A method for using a fecal bacteria capsule based on fecal bacteria as claimed in claim 1 or 2, characterized in that: The number of live bacteria in a single fecal microbiota transplantation is ≥ 2.5 × 10 12 cfu .
